Compare AMTX & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMTX | BEAT |
|---|---|---|
| Founded | 2005 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Retail: Computer Software & Peripheral Equipment |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 98.6M | 82.7M |
| IPO Year | N/A | 2021 |
| Metric | AMTX | BEAT |
|---|---|---|
| Price | $1.64 | $1.42 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $17.00 | $6.75 |
| AVG Volume (30 Days) | ★ 1.1M | 883.0K |
| Earning Date | 03-13-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $201,323,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $139.04 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.22 | $0.54 |
| 52 Week High | $3.66 | $4.00 |
| Indicator | AMTX | BEAT |
|---|---|---|
| Relative Strength Index (RSI) | 50.68 | 29.32 |
| Support Level | $1.55 | $2.23 |
| Resistance Level | $1.83 | $2.60 |
| Average True Range (ATR) | 0.15 | 0.13 |
| MACD | 0.01 | -0.07 |
| Stochastic Oscillator | 38.89 | 1.06 |
Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. It owns and operates an approximately 65 million gallon per year ethanol production facility located in Keyes, California. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. It operates in the reportable geographic segments of North America and India.
HeartBeam Inc is a medical technology company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.